Featured Stem Cell Topics
Latest Articles
Weekly reads: oocytes from males, David Sinclair longevity inc, diabetes, He JiankuiA team led by Harvard professor David Sinclair had a recent Cell paper on reprogramming to fight aging that I reviewed here on The Niche. I thought the paper was exciting and important. Note that in vivo reprogramming was first done more than a decade ago. Sinclair did have a novel…
Where Kimera Labs fits into sphere of exosome companies
Today’s post takes a close look at the exosome manufacturer Kimera Labs in the context of the main exosome companies. What …
WHYY oh WHYY: NPR puff piece on risky stem cell microneedling
I usually associate NPR with solid journalism so I was scratching my head about a recent puff piece by WHYY …
Weekly reads: big CRISPR mtg, Mesoblast good news, Neuralink spiked
Where do things stand with potential applications of CRISPR and other gene editing technologies in patients? Overall, things are looking …
Weekly reads: human CRISPR, MRT risks, private IRBs, skincare
It’s funny how sometimes there are many new articles about one general topic like this week with heritable (and somatic) …
Visit Our Facebook Page
Visit our Stem Cell Channel on YouTube
Subscribe to Our Newsletter
Dr. Knoepfler’s TED talk
Authoritative stem cell information you can trust
UC Davis School of Medicine
Stem Cell Biologist & Founder
- Stem cells are all over the web, but accurate, science-based content is rare.
- Welcome to The Niche, the longest-running and #1 ranked stem cell blog.
- Award-winning cell biologist Dr. Paul Knoepfler has run the site for 12 years.
- We do stem cell research ourselves and publish papers so we’re experts.
- The Niche uniquely has no sponsored posts, and we battle dangerous hype.
- The site includes helpful resources and analysis of new papers.
- Our mission is to educate and empower.